Our latest volume and outcomes data in infographic form
Below we share recent volumes and outcomes from a sampling of centers in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/ea9de721-ec09-4ad1-99f4-42adbd7ce7a9/22-HVI-3341709-CQD-Inset1_jpg)
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/f9c71c7a-c496-4efe-ad3d-3dc1540d3bae/22-HVI-3341709-CQD-Inset-2_jpg)
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/7e34e53b-6726-4d7a-953b-2c8e0d50e483/22-HVI-3341709-CQD-Inset-3_jpg)
STS = Society of Thoracic Surgeons; ACC = American College of Cardiology; TVT = Transcatheter Valve Therapy
CABG = coronary artery bypass grafting; AVR = aortic valve replacement; MVRR = mitral valve repair/replacement; TAVR = transcatheter aortic valve replacement; MVR = mitral valve replacement
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/fe3cea6e-adbd-4bfe-852e-f5fc0f8d54d2/22-HVI-3341709-CQD-Inset-4_jpg)
(Source: National Cardiovascular Data Registry, CathPCI Registry®, American College of Cardiology Foundation, for rolling four-quarter period through Q4 2021)
STEMI = ST-elevation myocardial infarction
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/41aaaceb-b97d-40a9-bdd9-6f35b0c4754f/22-HVI-3341709-CQD-Inset-5_jpg)
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long-standing tradition of reporting volume and outcomes data across its various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Advertisement
Advertisement
They generally depend on the mutated gene, clone size and clinical setting
Large analysis adds to evidence that absolute diameter alone may miss vulnerable patients
Procedure places the center among only a handful worldwide to offer the minimally invasive approach
Phase 1 trial shows up to 97% decrease through 48 weeks with good tolerability
Post hoc ALPACA analysis boosts biological rationale for ongoing outcomes trial of lepodisiran
Durability findings propel potential one-time treatment approach to phase 1b testing
Practical takeaways for the reality of overlapping cardiovascular, kidney and metabolic disease
First prospective study shows early extubation and low vasoactive/inotropic medication use